Donna Lancaster

851 total citations
22 papers, 469 citations indexed

About

Donna Lancaster is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Genetics. According to data from OpenAlex, Donna Lancaster has authored 22 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 10 papers in Hematology and 6 papers in Genetics. Recurrent topics in Donna Lancaster's work include Acute Lymphoblastic Leukemia research (12 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Acute Myeloid Leukemia Research (4 papers). Donna Lancaster is often cited by papers focused on Acute Lymphoblastic Leukemia research (12 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Acute Myeloid Leukemia Research (4 papers). Donna Lancaster collaborates with scholars based in United Kingdom, United States and Netherlands. Donna Lancaster's co-authors include Lynne Lennard, J S Lilleyman, Amrana Qureshi, Lynley V. Marshall, Sarah Chittenden, Tim Eden, Phil Darbyshire, Anita WW Lim, Vaskar Saha and Andrew D.J. Pearson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Donna Lancaster

21 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donna Lancaster United Kingdom	10	200	180	119	91	80	22	469
C Béhar France	12	150 0.8×	182 1.0×	80 0.7×	74 0.8×	74 0.9×	34	421
Byung-Kiu Park South Korea	13	106 0.5×	86 0.5×	107 0.9×	121 1.3×	87 1.1×	27	495
Tanya Watt United States	9	107 0.5×	80 0.4×	99 0.8×	107 1.2×	44 0.6×	23	473
Justyna Kanold France	15	150 0.8×	296 1.6×	225 1.9×	109 1.2×	62 0.8×	50	638
Laura Burden United States	5	415 2.1×	377 2.1×	206 1.7×	94 1.0×	67 0.8×	7	605
Meerim Park South Korea	16	77 0.4×	191 1.1×	78 0.7×	119 1.3×	66 0.8×	49	521
Sadashivudu Gundeti India	11	101 0.5×	131 0.7×	49 0.4×	109 1.2×	90 1.1×	69	381
Eleonora Biasin Italy	10	86 0.4×	88 0.5×	97 0.8×	79 0.9×	30 0.4×	13	367
H. Spaar Germany	13	268 1.3×	155 0.9×	143 1.2×	90 1.0×	71 0.9×	35	548
Federico Sackmann‐Muriel Argentina	13	152 0.8×	144 0.8×	82 0.7×	98 1.1×	75 0.9×	25	396

Countries citing papers authored by Donna Lancaster

Since Specialization

Citations

This map shows the geographic impact of Donna Lancaster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Lancaster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Lancaster more than expected).

Fields of papers citing papers by Donna Lancaster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Lancaster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Lancaster. The network helps show where Donna Lancaster may publish in the future.

Co-authorship network of co-authors of Donna Lancaster

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Lancaster. A scholar is included among the top collaborators of Donna Lancaster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Lancaster. Donna Lancaster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vedi, Aditi, Geoff Shenton, Amélie Trinquand, et al.. (2024). Real‐world experience of paediatric acute promyelocytic leukaemia in the United Kingdom and Ireland. British Journal of Haematology. 206(1). 204–208.

Hijiya, Nobuko, C. Michel Zwaan, Carmelo Rizzari, et al.. (2019). Pharmacokinetics of Nilotinib in Pediatric Patients with Philadelphia Chromosome–Positive Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia. Clinical Cancer Research. 26(4). 812–820. 23 indexed citations

Carceller, Fernando, Steffen Hirsch, Komel Khabra, et al.. (2019). High-dose etoposide and cyclophosphamide in adults and children with primary refractory and multiply relapsed acute leukaemias: The Royal Marsden experience. Leukemia Research. 85. 106217–106217. 4 indexed citations

Gore, Lia, Pamela Kearns, Cármino Antônio De Souza, et al.. (2017). Phase II trial of dasatinib (DAS) in pediatric patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP).. Journal of Clinical Oncology. 35(15_suppl). 10511–10511. 1 indexed citations

Capsomidis, Anna, Andrew Hall, Hamid Daya, et al.. (2017). Vocal Cord Palsy in Children With Cancer: A 10-Year Analysis of UK Pediatric Intensive Care Admissions. Journal of Pediatric Hematology/Oncology. 39(4). 293–295. 4 indexed citations

Taj, Mary, et al.. (2016). Comparison of Presentation and Outcome in 100 Pediatric Hodgkin Lymphoma Patients Treated at Children Hospital, Lahore, Pakistan and Royal Marsden Hospital, UK.. PubMed. 26(11). 904–907. 6 indexed citations

George, Sally L., Nadia Falzone, Sarah Chittenden, et al.. (2016). Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma. Nuclear Medicine Communications. 37(5). 466–472. 30 indexed citations

Lashkari, Harsha Prasada, Donna Lancaster, Ayad Atra, M. P. Champion, & Mary Taj. (2011). Symptomatic severe hypertriglyceridaemia with asparaginase therapy in acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma: is rechallenging safe?. International Journal of Hematology. 94(6). 571–575. 9 indexed citations

Kearns, Pamela, Nikki Graham, M Cummins, et al.. (2011). Phase I study of clofarabine and liposomal daunorubicin in childhood acute myeloid leukemia.. Journal of Clinical Oncology. 29(15_suppl). 9521–9521. 2 indexed citations

10.

Shah, Anoop, et al.. (2009). Leukaemia survival trends in children with Down's syndrome in Great Britain, 1971–2000: a population-based study. Journal of Epidemiology & Community Health. 64(7). 604–609. 5 indexed citations

11.

Qureshi, Amrana, Lynley V. Marshall, & Donna Lancaster. (2008). Defibrotide in the prevention and treatment of veno‐occlusive disease in autologous and allogeneic stem cell transplantation in children. Pediatric Blood & Cancer. 50(4). 831–832. 38 indexed citations

12.

Lancaster, Donna, et al.. (2008). Intracranial hypertension in pediatric patients with acute lymphoblastic leukemia. Pediatric Blood & Cancer. 52(3). 418–420. 2 indexed citations

13.

Zwaan, C. Michel, Carmelo Rizzari, Vincent H. J. van der Velden, et al.. (2008). Dasatinib in Children and Adolescents with Relapsed or Refractory Leukemia: Interim Results of the CA180-018 Phase I Study from the ITCC Consortium.. Blood. 112(11). 3241–3241. 6 indexed citations

14.

Saran, Frank, Mark N. Gaze, Sarah Chittenden, et al.. (2007). Dosimetry for Fractionated ¹³¹ I-mIBG Therapies in Patients with Primary Resistant High-Risk Neuroblastoma: Preliminary Results. Cancer Biotherapy and Radiopharmaceuticals. 22(1). 105–112. 42 indexed citations

15.

Homfray, Tessa, et al.. (2007). Familial T-cell non-Hodgkin lymphoma caused by biallelic MSH2 mutations. Journal of Medical Genetics. 44(7). e83–e83. 35 indexed citations

16.

Roy, Anindita, Anna Cargill, Sharon Love, et al.. (2005). Outcome after first relapse in childhood acute lymphoblastic leukaemia – lessons from the United Kingdom R2 trial. British Journal of Haematology. 130(1). 67–75. 89 indexed citations

17.

Lancaster, Donna, Nishith Patel, Lynne Lennard, & J S Lilleyman. (2002). Leucocyte versus erythrocyte thioguanine nucleotide concentrations in children taking thiopurines for acute lymphoblastic leukaemia. Cancer Chemotherapy and Pharmacology. 50(1). 33–36. 32 indexed citations

18.

Dawson‐Hughes, Bess, Susan S. Harris, Gerard E. Dallal, Donna Lancaster, & Qi Zhou. (2002). Calcium Supplement and Bone Medication Use in a US Medicare Health Maintenance Organization. Osteoporosis International. 13(8). 657–662. 16 indexed citations

19.

Bashey, Asad, Suchitra Sundaram, Sue Corringham, et al.. (2001). Use of Capecitabine as First-Line Therapy in Patients with Metastatic Breast Cancer Relapsing After High- Dose Chemotherapy and Autologous Stem Cell Support. Clinical Oncology. 13(6). 434–437. 5 indexed citations

20.

Lancaster, Donna, Lynne Lennard, & J S Lilleyman. (1997). Profile of non-compliance in lymphoblastic leukaemia. Archives of Disease in Childhood. 76(4). 365–366. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact